Introduktion: Bröstcancer är den vanligaste cancerformen att drabba kvinnor och statistik visar att 1 av 14 kvinnor kommer drabbas av bröstcancer under sin livstid. Behandlingen för bröstcancer kan bidra till olika biverkningar som bland annat påverkar kvinnors sexuella hälsa. Syfte: Beskriva erfarenheter av sexuell hälsa hos kvinnor med bröstcancer. Metod: En beskrivande litteraturstudie baserat på resultatet från 10 vetenskapliga artiklar. Huvudresultat: Majoriteten av studiedeltagarna beskrev en förändring av den sexuella hälsan. Fåtalet upplevde ingen skillnad alls efter diagnos och behandling. Kvinnorna beskrev erfarenheter av minskad sexuell lust och smärtor som ledde till minskad sexuell aktivitet. De beskrev rädslor kopplat till sex och bröstcancer. Vissa upplevde en förändrad självkänsla på grund av kroppsliga förändringar. Kvinnorna beskrev erfarenheter av att ha sex trots att ingen lust fanns på grund av en vilja att göra sin partner tillfredsställd eller av religiösa skäl. Fåtalet kvinnor beskrev erfarenheter av en förbättrad sexuell hälsa i form av mer sexuell lust eller en starkare intim relation med sin partner efter diagnos och behandling. Slutsats: Kvinnorna har erfarenheter av en förändrad sexuell hälsa i samband med bröstcancer och behandling. Resultatet tyder på att det finns en brist på information och att vissa av kvinnorna saknar stöd från sjukvården gällande deras sexuella förändringar i samband med bröstcancer och behandling. Sjukvården bör därför erbjuda dessa kvinnor mer stöd och information om problem som kan uppstå för att främja kvinnornas sexuella hälsa. / Introduction: Breast cancer is the most common cancer to affect women and statistics show that 1 in 14 women will be affected by breast cancer in their lifetime. Treatment for breast cancer can contribute to a variety of side effects, including those affecting women's sexual health. The aim: To describe the sexual health experiences of women with breast cancer. Methods: A descriptive literature review based on the results of 10 scientific articles. Main results: The majority of study participants described a change in their sexual health. A few experienced no difference at all after diagnosis and treatment. The women described experiences of decreased sexual desire and pain leading to decreased sexual activity. They described fears related to sex and breast cancer. Some experienced a change in self-esteem due to physical changes. Women described experiences of having sex when there was no desire because of a desire to please their partner or for religious reasons. Few women described experiences of improved sexual health in terms of more sexual desire or a stronger intimate relationship with their partner after diagnosis and treatment. Conclusion: Women have experiences of a change in sexual health associated with breast cancer and treatment. The results suggest that there is a lack of information and that some of the women lack support from the health care system regarding their sexual changes related to breast cancer and treatment. Health care should therefore offer these women more support and information about problems that may arise in order to promote their sexual health.

Bakgrund: Bröstcancer är en av de vanligaste cancerformer som kvinnor insjuknar i och som leder till flest dödsfall. Behandligen mot bröstcancer består vanligtsvis av cytostaktikabehandling, kirurgi, hormonbehandling och strålbhenadling. Behandlingarna medför många oönskade och påfrestande biverkningar. Vilket påverkar kvinnans välmående och livskvalitet i efterförloppet. Både de fysiska och psykosociala problemen. Sjuksköterskan ska med empati stötta och utöva en god personcentrerad vård för att hjälpa kvinnorna att finna en sturktur i vardagen, syftet att främja hälsa och förebygga ohälsa.  Syfte: Syftet med studien var att belysa kvinnors upplevelser av det vardagliga livet efter att ha överlevt bröstcancer.  Metod: En litteraturstuide baserad på fyra patografier. Datamaerialet analyserades utifrån Lundman och Hällgren Graneheims kvaliatavita innehållsanalys.  Resultatet: Resultatet presenteras i tre kategorier och sex underkategorier. De tre huvudkategorierna var upplevad begränsningar i vardagslivet, känslan av förändrad kroppsbild och betydelsen av stödet. De sex underkatoegorierna var mental trötthet begränsar vardagen, känslan av oro för återfall påverkar vardagen, att kroppen förändras leder till negativia känslor, ökad livskvalitet tack vare bröstrekonstruktion, upplevt stöd från hälso- och sjukvården och upplevt stöd från omgivningen har betydelse.  Slutsats: Vardagslivet i efterförloppet har påverkats för alla kvinnor. Kvinnorna lever med mentaltrötthet. Detta påverlade deras vardag så pass att de inte orkade göra samma saker som innan. Kvinnorna hade en rädsla för att få återfall. Kvinnornas självkänsla påverkades av att de hade varit tvugna att genomgå mastektomi. Kvinnorna kände att de var i behov av stöd ifrån sjukvården i efterförloppet och berättade att stödet från anhöriga var en stor del i deras nya vardag.

Neuroblastoma constitutes roughly 8% of all childhood cancers where 95% of all neuroblastoma cases occur before the age of 10. The survival rate of infants and young children is very poor, which alone contributes to research novel biomarkers for classification methods, improved diagnosis and better anti-tumor therapies. The aim of this meta-analysis was to identify dysregulated miRNAs in neuroblastoma that has the potential to be used as antioncogenic biomarkers for diagnostic interventions. Additionally, explore miRNA interconnectedness on a systemic level and conversely extend the support of using miRNAs as biomarkers. A comprehensive literature search was performed within NIH-PubMed, NCBI-PMC and in the reference list of already reviewed publications, which yielded 9 eligible publications. Quality of evidence was assessed according to the guidelines adapted from MIAME, MINSEQE and MIQE. miRNet 2.0 was used to find the most significantly enriched annotations linked to neuroblastoma. A total of 251 samples (Cancer: 141; Control: 110) was reported by the 9 studies. These involved 66 dysregulated miRNAs (Up-regulated: 43; Down-regulated: 23) which was used for enrichment analysis. Four miRNAs (miR-17-5p, -92a-3p -421, -125b) were significantly linked to neuroblastoma, and associated secondary diseases; medulloblastoma (-92a-3p, -125b), bladder cancer (-17-5p, -125b), acute myeloid leukemia (-92a-3p, -125b) and cardiac hypertrophy (- 125b). miR-125b showed exceptional interconnectivity with these diseases and a multidimensional potential in neural tumorigenesis. This study showed that dysregulation and biological processes of these miRNAs were concurrent with the original studies, endorsing that these miRNAs have potential as diagnostic indicators or classifiers of such diseases. / Popular scientific summary Neuroblastoma (NB) is one of the most common types of pediatric neurological cancers in children and constitutes roughly 8% of all childhood cancer types, in which 95% of all NB cases occur before the age of 10. Even with frequent advancements in medical diagnosis and anti-tumor therapies, the current treatment options for patients with NB offers a survival rate that is very poor. This alone is a reason to pursue developing novel classification methods, improve diagnosis and research better anti-tumor therapies. Micro Ribonucleic Acids (miRNAs) are small non-coding single stranded biomolecules that have gotten a lot of attention in recent years due to their ability to regulate genes involved in various biological cancer processes, such as; tumor growth and development. miRNAs regulate these processes by altering the function of messenger RNAs (mRNAs), which are single-stranded biomolecules that resembles a piece of genetic code from the DNA of an organism cell. When these mRNAs become dysregulated, their cancer-promoting genes are disrupted which prevent them from working properly, leading to tumor regression or termination. The effect of this biological event is then objectively measured by using the miRNA as an indicator, also known as a biomarker. miRNA biomarkers have massive potential to improve various medical applications, such as; faster and more accurate diagnosis, detailed disease-classification and more precise drug trial predictions. However, a lot of individual studies have been published about the same miRNAs, which report a variation of conclusions. This makes it more difficult to determine the true nature of miRNAs. This issue can be addressed with systematic reviews and meta-analyses, which could yield additional support and give a broader picture of how miRNAs regulate different biological processes in NB. A meta-analysis is a scientific statistical process that combines the results of many research publications associated with the same scientific question and presents the best collective estimate of truth with increased precision than what could be achieved from individual studies alone. Thus, meta-analysis is an important tool in research which makes sure that the most trustworthy effect estimate can be achieved among many similar answers. The aim of this meta-analysis was to identify dysregulated miRNAs in NB that has the potential to be used as anti-cancer promoting biomarkers for diagnostic interventions. Additionally, explore how different miRNAs are connected to NB and conversely extend the support of using miRNAs as biomarkers. The end goal of this meta-analysis is to provide more reliable evidence for further research that can improve the life expectancy of NB patients in the future. In this study, 4 miRNAs (miR-17-5p, -92a-3p -421 and -125b) were identified to be significantly linked to NB, and associated secondary diseases; medulloblastoma (-92a-3p & -125b), bladder cancer (-17-5p & -125b), acute myeloid leukemia (-92a-3p & -125b) and cardiac hypertrophy (- 125b). Specifically, miR-125b showed exceptional interconnectivity for these diseases and potential to indirectly down-regulate n-Myc in NB, a gene that promote cancer cell proliferation. miR-125b was also found to be a significant sole regulator and effector of the CDX2 gene responsible for cancer cell differentiation in acute myeloid leukemia, a relationship that has been supported by other publications. This meta-analysis showed that the reported dysregulation and biological processes of these miRNAs were concurrent with the original studies, endorsing that these miRNAs have potential as diagnostic indicators or classifiers of such diseases while warranting that the gene regulatory function of miRNAs are becoming more intricate than previously thought.

No description available.

High-grade serous ovarian cancer (HGSOC) is the most aggressive subtype of ovarian cancer, and its heterogeneity poses a challenge for the discovery of reliable diagnostic biomarkers, therapeutic targets, and predicting treatment response, particularly to immunotherapy. The current standard diagnostic and treatment options are inadequate, resulting in late diagnosis and poor prognosis. To improve our understanding of the immunophenotype of tumours, potentially enhancing diagnostic and treatment capabilities, the aim of the present study was to develop a stringent workflow for studying the immune microenvironment of HGSOC tumours. We utilized publicly available single-cell RNA sequencing data and literature to identify genes enriched in certain cell types of HGSOC tumours, followed by validation using immunofluorescent-based multiplex protein profiling. A 9-plex immunofluorescence workflow was developed using the Opal™ system, and quantitative image analysis was performed to evaluate the expression of PD-L1, CD8A, FoxP3, CD163, KRT7, PDGFRB, and CD79A in large tissue sections of ovarian cancer. Each of these markers are specific to different cell types, and by staining the multiplex marker panel together with new markers with little or no literature linked to HGSOC we can gain novel insights on the immune microenvironment of HGSOC. In this project, for a proof of concept, we focused on two proteins; GZMK and SLAMF7. The optimized multiplex panel developed as part of this project will be used to identify cell-type-specific markers that may play a crucial role in the immune microenvironment of HGSOC, which could lead to better immunophenotype stratification of patients and a more optimal immunotherapy response. Moreover, the panel could also be used to study markers of less well-known immune cell types, further improving our understanding of HGSOC. Overall, this project has the potential to significantly contribute to the development of reliable diagnostic biomarkers and therapeutic targets for HGSOC, ultimately improving patient outcomes.

Pancreatic cancer is a form of severe neoplasm with a swift disease progression and a high rate of mortality. It is the 12th leading cause of death globally for all cancer-related mortalities. Diagnosis is often late in the disease progression due to the late manifestation of symptoms which limits curative treatment options, resulting in primary palliative treatments. Patients experience a broad variety of symptoms that affect their physical and mental health causing a tremendous symptom burden. Therefore, the aim of this study was to describe the patient’s experience of living with pancreatic cancer. A literature review of qualitative and quantitative research articles was conducted to answer the purpose of this study. Data was collected through Cinahl, PsycINFO and PubMed and generated eleven articles which were analyzed, nine qualitative and two quantitative. The results were presented in two categories living in uncertainty which presented the patients emotions associated with getting the diagnosis together with unmeet informational needs and living with an unwell body which presented the physical bodily changes. This study concluded that pancreatic cancer has a significant impact on both the patients’ physical and mental health. Furthermore, there was a correlation between physical and psychological symptoms that all affected the patients' state of well-being. Moreover, patients experienced a lack of sufficient information concerning the disease. Therefore, it is of utmost importance that the patient is seen as a whole entity by the healthcare personnel to meet the individual care needs that arise from the illness.

Bakgrund: Årligen diagnostiseras cirka 400 000 barn i världen med cancer, medvarierande överlevnadschanser beroende på var barnet bor. En cancerdiagnos medför ofta en stor livsomställning för alla inblandade och mötet med barncancer kan upplevas som svårt. Genom att undersöka barnens perspektiv och erfarenheter av cancer kan förståelsen och bemötandet till dessa barn förbättras. Syfte: Syftet var att beskriva barns erfarenheter av att leva med cancer. Metod: Litteraturstudien har en deskriptiv design och artiklarna i resultatet söktes fram via databasen PubMed. Totalt valdes 13 artiklar ut som svarade på syftet. Huvudresultat: Resultaten visade att barn med cancer genomgick många utmaningar som berörde dem fysiskt, psykiskt och socialt. Fysiska utmaningar innefattade främst smärta, rörelsebegränsningar, trötthet samt illamående och kräkningar. Psykiska utmaningar lyfte barnens olika känslor. Vanligast var rädsla, sorg och orättvisa. Sociala utmaningar inkluderade förändrade relationer samt upplevd isolering. Barnen hanterade utmaningarna genom olika strategier, innefattande positiv inställning och stöd från närstående samt vårdpersonal. De upplevde att cancern bidragit till personlig utveckling och givit nya livsperspektiv. Slutsats: Barns erfarenheter av att leva med cancer framställer åtskilliga utmaningar som de behövde hantera under sjukdomen. Känslorna speglades av cancerns olika faser och gjorde att barnen konstant pendlade mellan hopp och förtvivlan. Denna litteraturstudie kan ha en betydande roll för sjuksköterskor inför mötet med barn som lever med cancer. En ökad förståelse för barns cancererfarenheter kan underlätta bemötandet av barnens individuella behov, samt bidra till att främja barnens vårdupplevelser. / Background: About 400 000 children worldwide are annually diagnosed with cancer, with varying chances of survival depending on where the child lives. A cancer diagnosis often entails a major life change for everyone involved and the encounter with childhood cancer can be experienced as difficult. By examining the children's perspective and experiences of cancer, the comprehension and personal treatment of these children can be improved. Aim: The aim was to describe children's experiences of living with cancer. Method: The literature study has a descriptive design and the articles in the result were found through the database PubMed. A total of 13 articles were selected that responded to the aim. Main results: The results showed that children with cancer went through many challenges that affected them physically, psychologically and socially. Physical challenges mainly included pain, movement restrictions, fatigue as well as nausea and vomiting. Psychological challenges emphasized the children's different emotions. Most common were fear, sadness and injustice. Social challenges included changed relationships and perceived isolation. The children handled the challenges through various strategies, including positive attitude and support from relatives and health care professionals. They felt that the cancer contributed to personal development and gave new life perspectives. Conclusion: Children's experiences of living with cancer present several challenges that they needed to deal with during the illness. The feelings were reflected by the different phases of cancer, which caused the children to constantly oscillate between hope and despair. This literature study could have a significant role for nurses before facing children living with cancer. An increased understanding of children's cancer experiences can facilitate children's individual needs, as well as contribute to promoting children's health care experiences.

Background: Radiation therapy used for head and neck cancer patients cause many side effects in the oral cavity and above all affects the salivary glands. Complaint of dry mouth (xerostomia) and hyposalivation are common as well as swallowing difficulty (dysphagia) even after the cancer is remitted.  Aim: The aim of the study is to examine the correlation between hyposalivation and xerostomia in patients undergoing radiotherapy.   Methods: Six patients undergoing radiotherapy for head and neck cancer at Norrlands University Hospital participated in the study. A questionnaire regarding xerostomia was answered and a collection of stimulated as well as unstimulated saliva was taken.  Results: Regarding the stimulated salivary flowrate, one out six patients was below the limit of hyposalivation. Three out of six patients were below the limit of hyposalivation with reference to the unstimulated salivary output. The questionnaire regarding xerostomia showed that all patients experienced dry mouth symptoms to varying degrees. The questions concerning the dryness of the tongue and the amount of saliva in the mouth had the highest rating.  Conclusion: Regarding the patients that participated in this study, a correlation is shown between xerostomia and unstimulated salivary output. However, due to the lack of participants in the study, no firm conclusion can be drawn.

Bakgrund: Bröstcancer är idag den vanligaste cancerformen som drabbar kvinnor i världen. För unga kvinnor under 45 årsåldern riskerar endast 4-6% att drabbas av bröstcancer vilket utgör diagnosen till en ovanlig sjukdom. På grund av bröstcancerns svåra patologi och dess unika prognostik krävs särskild uppmärksamhet hos unga kvinnor då cancern påverkar flera aspekter på livet som fertilitet, familjeliv och karriär.  Syfte: Syftet med litteraturöversikten var att beskriva den unga kvinnans upplevelser av att leva med bröstcancer.  Metod: Studien är en kvalitativ litteraturstudie innefattande av tolv artiklar där en kvalitativ innehållsanalys tillämpats vid analysering av data.  Resultat: Olika upplevelser som identifierades i de inkluderade artiklarna kunde sammankopplas under följande huvudkategorier: 1) Den unga kvinnans sexuella hälsa, 2) Ångest och livskris, 3) Den sociala aspekten.  Slutsatser: Olika upplevelser identifierades hos unga kvinnor under deras bröstcancerdiagnos. För att öka sjuksköterskors förståelse för unga bröstcancerpatienter och möjliggöra implementationen av förbättrad vård bör sjuksköterskestudenter och nuvarande sjuksköterskor utbildas om omvårdnad vid unga bröstcancerpatienter. / Background: Breast cancer is today the most common form of cancer that affects women in the world. For young women under the age of 45, only 4-6% are at risk of suffering from breast cancer, which constitutes the diagnosis of an unusual disease. Due to the difficult pathology of breast cancer and its unique prognosis, special attention is required in young women as the cancer affects several aspects of life such as fertility, family life and career. Aim: The purpose of the literature review was to describe the young woman's experiences of living with breast cancer. Method: The study is a qualitative literature study comprising twelve articles where a qualitative content analysis is applied when analyzing the data. Results: Different experiences identified in the included articles could then be linked under the following main categories: 1) The young woman's sexual health, 2) Anxiety and lifecrisis, 3) The social aspect. Conclusion: Different experiences were identified in young women during their breast cancer diagnosis. In order to increase nurses' understanding of young breast cancer patients and enable the implementation of improved care, nursing students and current nurses should be educated about nursing care for young breast cancer patients.

A high expression of stromal PDGFRβ is known to be a poor prognosis marker in several solid tumor types. However, the role of stromal PDGFRβ for non-small cell lung cancer (NSCLC) patients remains unclear. Therefore, we investigated the activation status of PDGFRβ with proximity ligation assay (PLA) by studying the interaction between the receptor and GRB2, one of PDGFRβs downstream signaling molecules. The main aim is in this study is to investigate the activation status of stromal PDGFRβ in NSCLC tissues and look into its clinical relevance for lung cancer patients. Our data revealed that PDGFRβ activation status did not affect overall survival, and was not associated to smoking, sex, age or stage of cancer. PDGFRβ activation status was higher in the histological subgroup of squamous cell carcinoma-patients compared to the adenocarcinoma subgroup. The PDGFRβ activation status showed a clear correlation to the general expression level of PDGFRβ investigated by immunohistochemistry (IHC). The correlation also showed that a high activation status required a high general expression, indicating a specific pipeline.